Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8617
|
pubmed:dateCreated |
1988-11-22
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
22
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
969-70
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2902420-Adult,
pubmed-meshheading:2902420-Drug Therapy, Combination,
pubmed-meshheading:2902420-Humans,
pubmed-meshheading:2902420-Levodopa,
pubmed-meshheading:2902420-Male,
pubmed-meshheading:2902420-Neuroleptic Malignant Syndrome,
pubmed-meshheading:2902420-Schizophrenia,
pubmed-meshheading:2902420-Tranquilizing Agents
|
pubmed:year |
1988
|
pubmed:articleTitle |
Clinical spectrum of neuroleptic malignant syndrome.
|
pubmed:publicationType |
Letter,
Case Reports
|